{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:35:49Z","timestamp":1767706549408},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.pupt.2012.07.004","type":"journal-article","created":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:52:32Z","timestamp":1343263952000},"page":"392-398","source":"Crossref","is-referenced-by-count":10,"title":["Relief of methacholine-induced bronchospasm with extrafine beclomethasone dipropionate\/formoterol in comparison with salbutamol in asthma"],"prefix":"10.1016","volume":"25","author":[{"given":"Dave","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Corradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eddi","family":"Bindi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Baronio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Petruzzelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Paggiaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2012.07.004_bib1","unstructured":"Global Initiative for Asthma, update 2010. [http\/\/www.ginasthma.org]."},{"key":"10.1016\/j.pupt.2012.07.004_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1081-1206(10)61365-8","article-title":"The use of inhaled formoterol in the treatment of asthma","volume":"97","author":"Berger","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.pupt.2012.07.004_bib3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1183\/09031936.03.00055803","article-title":"Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial","volume":"22","author":"Pauwels","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2012.07.004_bib4","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1164\/rccm.200401-033OC","article-title":"Can guideline-defined asthma control be achieved? The gaining optimal asthma control study","volume":"170","author":"Bateman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2012.07.004_bib5","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/j.1398-9995.2008.01863.x","article-title":"Budesonide\/formoterol for maintenance and reliever therapy in the management of moderate to severe asthma","volume":"63","author":"Humbert","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.pupt.2012.07.004_bib6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1183\/09031936.00080306","article-title":"Scientific rationale for using a single inhaler for asthma control","volume":"29","author":"Barnes","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2012.07.004_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1465-9921-7-141","article-title":"Onset of relief of dyspnoea with budesonide\/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study","volume":"7","author":"Jonkers","year":"2006","journal-title":"Respir Res"},{"key":"10.1016\/j.pupt.2012.07.004_bib8","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1398-9995.2007.01493.x","article-title":"Beclometasone\/formoterol vs fluticasone\/salmeterol inhaled combination in moderate to severe asthma","volume":"62","author":"Papi","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.pupt.2012.07.004_bib9","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1183\/09031936.00095906","article-title":"Beclometasone\/formoterol versus budesonide\/formoterol combination therapy in asthma","volume":"29","author":"Papi","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2012.07.004_bib10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/14656566.9.3.479","article-title":"Inhaled beclometasone dipropionate\/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectives","volume":"9","author":"Fabbri","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.pupt.2012.07.004_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2012.07.004_bib12","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0954-6111(98)90140-8","article-title":"A\u00a0comparison of the onset of action of salbutamol and formoterol in reversing methacholine-induced bronchoconstriction","volume":"92","author":"Van Noord","year":"1998","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2012.07.004_bib13","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1034\/j.1399-3003.1999.13e10.x","article-title":"Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction","volume":"13","author":"Politiek","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2012.07.004_bib14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.rmed.2004.03.001","article-title":"Relief of dyspnoea by beta2-agonists after methacholine-induced bronchoconstriction","volume":"98","author":"Van der Woude","year":"2004","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2012.07.004_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pupt.2003.11.001","article-title":"Budesonide\/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction","volume":"17","author":"Van der Woude","year":"2004","journal-title":"Pulm Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.pupt.2012.07.004_bib16","first-page":"1330","article-title":"Guidelines for the diagnosis and management of asthma-summary report 2007. National asthma education and prevention program","volume":"121","author":"Expert Panel Report 3 (EPR-3)","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.pupt.2012.07.004_bib17","first-page":"CD008418","article-title":"Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma","volume":"9","author":"Welsh","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pupt.2012.07.004_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/pulp.1996.0031","article-title":"Speeds of action of single doses of formoterol and salbutamol compared with placebo in reversing methacholine-induced bronchoconstriction","volume":"9","author":"Beach","year":"1996","journal-title":"Pulm Pharmacol"},{"key":"10.1016\/j.pupt.2012.07.004_bib19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1053\/rmed.2001.1161","article-title":"Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (foradil aerolizer) with salbutamol (ventodisk)","volume":"95","author":"Benhamou","year":"2001","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2012.07.004_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/thx.47.1.30","article-title":"Time course of bronchodilating effect of inhaled formoterol, a potent and long acting sympathomimetic","volume":"47","author":"Derom","year":"1992","journal-title":"Thorax"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553912001150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553912001150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T22:28:54Z","timestamp":1542839334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553912001150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1094553912001150"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2012.07.004","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}